City State Bank’s Edwards Lifesciences EW Stock Holding History

City State Bank’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$47.9K	Hold	530	–	–	0.01%	367
2026 Q1	$42.4K	Sell	530 -37	-7%	-$3.05K	0.01%	379
2025 Q4	$48.3K	Hold	567	–	–	0.01%	354
2025 Q3	$44.1K	Sell	567 -100	-15%	-$7.81K	0.01%	356
2025 Q2	$52.2K	Hold	667	–	–	0.02%	334
2025 Q1	$48.3K	Hold	667	–	–	0.02%	343
2024 Q4	$49.4K	Sell	667 -250	-27%	-$17.5K	0.02%	326
2024 Q3	$60.5K	Hold	917	–	–	0.02%	302
2024 Q2	$84.7K	Buy	917 +130	+17%	+$11.5K	0.03%	262
2024 Q1	$75K	Hold	787	–	–	0.03%	272
2023 Q4	$60K	Hold	787	–	–	0.03%	280
2023 Q3	$55K	Hold	787	–	–	0.03%	283
2023 Q2	$74K	Hold	787	–	–	0.04%	258
2023 Q1	$65K	Hold	787	–	–	0.04%	260
2022 Q4	$59K	Buy	787 +150	+24%	+$11.6K	0.04%	261
2022 Q3	$53K	Hold	637	–	–	0.04%	257
2022 Q2	$61K	Buy	637 +50	+9%	+$5.18K	0.04%	244
2022 Q1	$69K	Hold	587	–	–	0.04%	250
2021 Q4	$76K	Buy	+587	New	+$68.5K	0.05%	248

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

City State Bank's EW Position: Q2 2026 in Review

City State Bank held its Edwards Lifesciences (EW) position steady in Q2 2026 at 530 shares worth $47.9K. The position accounts for 0.01% of the portfolio, ranked #367.

City State Bank first reported a position in EW in Q4 2021 and has held it in 19 quarters since. The position peaked at $84.7K in Q2 2024. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

City State Bank held 530 shares of Edwards Lifesciences worth $47.9K as of Q2 2026.
City State Bank left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up 0.01% of City State Bank's portfolio in Q2 2026, its #367 holding.
City State Bank first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 19 quarters since.
City State Bank's Edwards Lifesciences position peaked at $84.7K in Q2 2024.
563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.